{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15491100", "DateCompleted": {"Year": "2005", "Month": "02", "Day": "01"}, "DateRevised": {"Year": "2016", "Month": "11", "Day": "24"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"ISSN": "0513-4870", "JournalIssue": {"Volume": "39", "Issue": "6", "PubDate": {"Year": "2004", "Month": "Jun"}}, "Title": "Yao xue xue bao = Acta pharmaceutica Sinica", "ISOAbbreviation": "Yao Xue Xue Bao"}, "ArticleTitle": "[Structural modification and bioactivity of cyclovirobuxine D].", "Pagination": {"StartPage": "434", "EndPage": "438", "MedlinePgn": "434-8"}, "Abstract": {"AbstractText": ["To search for new compounds for the treatment of cardiovascular diseases by structural modification of cyclovirobuxine D.", "According to rational drug design principle, a series of cyclovirobuxine D analogues were prepared, and their bioactivities were tested.", "Ten new compounds were syntheized and confirmed by spectra.", "Endurance lacking oxygen activity and antiarrhythmia effects of some analogues of cyclovirobuxine D were tested. Some compounds showed better activity than cyclovirobuxine D."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "West China School of Pharmacy, Sichuan University, China. denglan234@sina.com"}], "Identifier": [], "LastName": "Deng", "ForeName": "Lan", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Huang", "ForeName": "Heng", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Xu", "ForeName": "Ming-xia", "Initials": "MX"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhou", "ForeName": "Shi-qing", "Initials": "SQ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Xing-wen", "Initials": "XW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lu", "ForeName": "Miao", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ren", "ForeName": "Fang", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Li", "ForeName": "Dai-qing", "Initials": "DQ"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Yao Xue Xue Bao", "NlmUniqueID": "21710340R", "ISSNLinking": "0513-4870"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Arrhythmia Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "51GY352868", "NameOfSubstance": "cyclovirobuxine D"}, {"RegistryNumber": "7V31YC746X", "NameOfSubstance": "Chloroform"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Anaerobic Threshold"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Anti-Arrhythmia Agents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Buxus"}, {"QualifierName": [], "DescriptorName": "Chloroform"}, {"QualifierName": ["chemical synthesis", "isolation & purification", "pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Random Allocation"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Ventricular Fibrillation"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2004", "Month": "10", "Day": "20", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "2", "Day": "3", "Hour": "9", "Minute": "0"}, {"Year": "2004", "Month": "10", "Day": "20", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15491100"]}}], "PubmedBookArticle": []}